glp-1 and kidney disease Glucagon-like peptide 1(GLP-1) receptor agonists in the management of the patient with type 2diabetes mellitus chronic disease: an approach for the nephrologist SGLT2is, GLP-1RAs, and GIP/GLP-1RAs for

Differentiation of Substrate and Non-Substrate Inhibitors of Transport System Xc(-): An Obligate Exchanger of L-Glutamate and L-Cystine

Native IGF-1 has an extremely short half-life of about 10 minutes, needing very frequent use for sustained effects

Around 97% of Oura members have said they want to understand how their bodies respond to food, Hale added

Improved exercise performance and faster recovery

Further information and requests for resources and reagents should be directed to and will be fulfilled by the corresponding author, Benot Malleret ([email protected])

Medicine regulator updates weight loss jab guidance to include pancreatitis risk People who take weight loss jabs have been urged to stay alert to the symptoms of an infrequent but potentially severe side effect of the drugs by the medicines regulator